secwatch.observer — SEC 8-K summary
======================================

Issuer:     DEXCOM INC (DXCM)
CIK:        0001093557
Form:       8-K
Filed at:   2024-05-24T23:59:59+00:00
Accession:  0001093557-24-000101
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

DexCom annual meeting results: directors elected, EY ratified, say-on-pay approved, two shareholder proposals decided
--------------------------------------------------------------------------------

- Stockholders elected all 10 director nominees; Kevin R. Sayer received 319.8M votes for, 19.8M against.
- Ratified Ernst & Young as independent auditor for FY2024 with 329.3M votes for, 23.4M against.
- Advisory vote on named executive officer compensation approved with 307.9M for, 33.4M against.
- Stockholder proposal on pay equity disclosure failed (118.6M for, 211.8M against).
- Stockholder proposal on transparency in lobbying passed (176.1M for, 163.3M against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1093557/000109355724000101/0001093557-24-000101-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1093557/000109355724000101/dxcm-20240522.htm
  HTML page:      https://secwatch.observer/filing/0001093557-24-000101

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer